10-K: AquaBounty Technologies Faces Financial Hurdles, Pauses Ohio Farm Construction

AquaBounty Technologies reports a pause in construction of its Ohio farm due to increased costs and is exploring strategic alternatives, including the sale of its Indiana farm.

Summary

• AquaBounty Technologies, a company focused on genetically engineered salmon, has paused construction of its large-scale farm in Pioneer, Ohio, due to substantial cost increases.
• The company's initial cost estimate for the Ohio farm has risen significantly, exceeding their ability to complete the proposed financing.
• To address this, AquaBounty is seeking new financing and exploring strategic options, including selling its Indiana farm.
• The company is also considering debt financing secured by unencumbered assets and potential joint venture partnerships.
• AquaBounty's 2023 revenue was $2.47 million, down from $3.14 million in 2022, primarily due to changes in product mix and decreased market prices for Atlantic salmon.
• The company reported a net loss of $27.56 million for 2023, compared to a $22.16 million loss in 2022.
• As of December 31, 2023, AquaBounty had $9.2 million in cash, cash equivalents, and restricted cash.
• The company has a history of net losses, with a cumulative loss of approximately $221 million since inception.
• AquaBounty is also pursuing regulatory approval for its GE Atlantic salmon in Israel and plans to expand into shrimp aquaculture.

Sentiment

Score: 3

Explanation: The document reveals significant financial challenges, including a pause in construction, increased losses, and a need for substantial additional capital. While there are some positive aspects, the overall tone is negative due to the company's financial instability and operational setbacks.

Positives

• AquaBounty has over 25 years of experience growing salmon in land-based recirculating aquaculture systems (RAS).
• The company's GE Atlantic salmon has received regulatory approvals in the United States, Canada, and Brazil.
• AquaBounty is vertically integrated, maintaining its own broodstock hatchery.
• The company is exploring expansion into other aquaculture species, such as shrimp.
• AquaBounty is focused on sustainable practices, including water management and waste reduction.
• The company has scaled up its egg production capability and is selling excess conventional salmon eggs and fry.
• The company is aligned with several United Nations Sustainable Development Goals.

Negatives

• AquaBounty has a history of net losses and expects to incur future losses.
• There is substantial doubt about the company's ability to continue as a going concern.
• The company requires substantial additional capital to implement its business strategy.
• Construction of the Ohio farm is paused due to significant cost increases.
• The company's revenue decreased in 2023 compared to 2022.
• The company is dependent on third parties for processing, distribution, and sale of its products.
• The company faces ethical, legal, and social concerns about genetically engineered products.

Risks

• The company may not be able to raise sufficient capital on acceptable terms or at all.
• Delays and defects may prevent the commencement of farm operations.
• Rising inflation rates could negatively impact revenues and profitability.
• The financing of the Ohio farm through municipal bonds may require restrictive debt covenants.
• The company may encounter difficulties managing its growth.
• High customer concentration exposes the company to various risks.
• The company may have limited success in gaining consumer acceptance of its products.
• The company may experience a significant fish mortality event.
• The company is subject to security breaches and cyber-attacks.
• The company may be required to write down the value of its inventory.
• The company is subject to industry volatility, including fluctuations in commodity prices of salmon.
• The company may not be able to maintain its listing on Nasdaq.
• The company may issue preferred stock that could dilute the voting power or reduce the value of its common stock.

Future Outlook

AquaBounty plans to complete the construction of its Ohio farm, expand egg production, pursue regulatory approval in Israel, and explore opportunities in shrimp aquaculture. The company is also exploring the potential development of a second generation of its GE Atlantic salmon and improved methods for generating genetically engineered fish.

Management Comments

• The company is pursuing a range of funding and strategic alternatives, including the recently announced sale process for our Indiana farm, potential debt financing secured by our unencumbered assets, and potential joint venture partnerships or other strategic transactions.
• We believe we are a leader in the field of land-based aquaculture and the use of technology for improving its productivity and sustainability.
• Our objective is to ensure the availability of high-quality seafood to meet growing global consumer demand, while addressing critical production constraints in one of the most popular farmed species.

Industry Context

The document highlights the growing demand for fish protein and the limitations of traditional fisheries, positioning aquaculture as a necessary solution. It also notes the challenges of conventional sea-cage salmon farming, such as disease outbreaks and environmental concerns, which AquaBounty aims to address with its land-based RAS technology. The document also mentions the presence of large competitors in the salmon farming industry, as well as new entrants using land-based RAS facilities.

Comparison to Industry Standards

• The document notes that global Atlantic salmon aquaculture harvests grew by approximately 5% annually between 2017 and 2022, reaching 2.9 million metric tons with a value of $22 billion, indicating a growing market.
• The company competes against established sea-cage production companies like Mowi, SalMar, and Aquachile, which account for a significant portion of the market.
• New entrants to salmon production using land-based RAS facilities, such as Atlantic Sapphire and Nordic Aquafarms, are also mentioned as competitors.
• The document states that AquaBounty's GE Atlantic salmon can grow to market size faster than conventional farmed salmon, reducing farming time from 26-28 months to 18-20 months, and is 25% more efficient at converting feed to biomass.
• The company's land-based RAS production systems are less susceptible to disease-related pressures compared to conventional sea-cage farming, reducing the need for antibiotics and vaccines.

Stakeholder Impact

• Shareholders face the risk of further dilution and potential loss of investment due to the company's financial difficulties.
• Employees may experience uncertainty due to the company's financial instability and potential restructuring.
• Customers may face potential disruptions in supply due to the pause in construction and potential sale of the Indiana farm.
• Suppliers may face uncertainty regarding future contracts and payments.
• Creditors face increased risk due to the company's financial challenges.

Next Steps

• AquaBounty will seek new financing to resume construction of its Ohio farm.
• The company will explore strategic alternatives, including the sale of its Indiana farm.
• AquaBounty will continue to pursue regulatory approval for its GE Atlantic salmon in Israel.
• The company plans to expand its egg production and sales.
• AquaBounty will explore opportunities in shrimp aquaculture.

Key Dates

Keywords

genetically engineered salmon, aquaculture, land-based RAS, recirculating aquaculture systems, Atlantic salmon, fish farming, biotechnology, sustainable seafood, capital raise, financial results